MX9603124A - Vacuna contra el virus de la enfermedad de newcastle benigna. - Google Patents

Vacuna contra el virus de la enfermedad de newcastle benigna.

Info

Publication number
MX9603124A
MX9603124A MX9603124A MX9603124A MX9603124A MX 9603124 A MX9603124 A MX 9603124A MX 9603124 A MX9603124 A MX 9603124A MX 9603124 A MX9603124 A MX 9603124A MX 9603124 A MX9603124 A MX 9603124A
Authority
MX
Mexico
Prior art keywords
disease virus
newcastle disease
mild
virus vaccine
poultry
Prior art date
Application number
MX9603124A
Other languages
English (en)
Other versions
MXPA96003124A (es
Inventor
Carla Christina Schrier
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of MXPA96003124A publication Critical patent/MXPA96003124A/es
Publication of MX9603124A publication Critical patent/MX9603124A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion provee la cepa C2 del virus de la enfermedad de Newcastle, que es capaz de inducir una respuesta inmunologica solida en aves de corral, sin reacciones de vacunacion adversas.
MX9603124A 1995-08-01 1996-07-31 Vacuna contra el virus de la enfermedad de newcastle benigna. MX9603124A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50991495A 1995-08-01 1995-08-01
US509914 1995-08-01
US509,914 1995-08-01

Publications (2)

Publication Number Publication Date
MXPA96003124A MXPA96003124A (es) 1997-06-01
MX9603124A true MX9603124A (es) 1997-06-28

Family

ID=24028630

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9603124A MX9603124A (es) 1995-08-01 1996-07-31 Vacuna contra el virus de la enfermedad de newcastle benigna.

Country Status (11)

Country Link
US (1) US5750111A (es)
EP (1) EP0760394B1 (es)
JP (1) JP3945842B2 (es)
AT (1) ATE206754T1 (es)
BR (1) BR9603227A (es)
CA (1) CA2181862C (es)
DE (1) DE69615772T2 (es)
DK (1) DK0760394T3 (es)
ES (1) ES2165466T3 (es)
MX (1) MX9603124A (es)
PT (1) PT760394E (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978434B (en) * 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.
CA2312626A1 (en) 1999-07-27 2001-01-27 Akzo Nobel N.V. A recombinant newcastle disease virus as an embryo vaccine
EP1074614B1 (en) * 1999-07-27 2004-07-07 Akzo Nobel N.V. A recombinant Newcastle disease virus for in ovo vaccination
US20030215455A1 (en) * 2002-05-14 2003-11-20 Bailey Reynolds Vaccine stabilizer and method of use
TW200502402A (en) * 2002-12-06 2005-01-16 Wyeth Corp Escape mutants of newcastle disease virus as marker vaccines
ATE424844T1 (de) * 2003-12-23 2009-03-15 Intervet Int Bv Kombinationsvakzine für geflügel
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
US20120231033A1 (en) * 2009-12-01 2012-09-13 Carla Christina Schrier Inactivated poultry vaccine
CN112662633A (zh) * 2020-12-28 2021-04-16 中国水产科学研究院珠江水产研究所 II型草鱼呼肠孤病毒冷适应株GCRV-GD108ca及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2767117A (en) * 1953-10-22 1956-10-16 Crawley John Frederick Poultry virus vaccine products and method of preparing the same
US4053583A (en) * 1976-03-01 1977-10-11 Smithkline Corporation Live newcastle disease virus vaccines
BE853923A (fr) * 1977-04-25 1977-10-25 Rit Rech Ind Therapeut Nouveau vaccin vivant ameliore contre le pseudopeste aviaire et son procede de preparation
SU826584A1 (ru) * 1979-10-29 1982-11-07 Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Вакцина против ньюкаслской болезни птиц,способ ее изготовлени и способ профилактики ньюкаслской болезни птиц
DE68918649T2 (de) * 1988-07-18 1995-03-23 Duphar Int Res Lebende Newcastle-Krankheit-Virus-Vakzine.
US5250298A (en) * 1988-10-07 1993-10-05 University Of Delaware Live attenuated newcastle disease virus vaccines and preparation thereof
HU203983B (en) * 1988-12-05 1991-11-28 Mta Allatorvostudomanyi Kutato Process for producing living vaccine against fowlpox
US5118502A (en) * 1989-06-20 1992-06-02 The University Of Georgia Research Foundation, Inc. Naturally attenuated newcastle disease vaccine and method of using the same
US5427791A (en) * 1992-08-05 1995-06-27 Regents Of The University Of Minnesota Embryonal vaccine against Newcastle disease

Also Published As

Publication number Publication date
ES2165466T3 (es) 2002-03-16
EP0760394B1 (en) 2001-10-10
JPH09154572A (ja) 1997-06-17
DK0760394T3 (da) 2002-01-21
EP0760394A1 (en) 1997-03-05
BR9603227A (pt) 1998-04-22
JP3945842B2 (ja) 2007-07-18
ATE206754T1 (de) 2001-10-15
DE69615772D1 (de) 2001-11-15
CA2181862A1 (en) 1997-02-02
DE69615772T2 (de) 2002-08-01
US5750111A (en) 1998-05-12
CA2181862C (en) 2009-12-22
PT760394E (pt) 2002-04-29

Similar Documents

Publication Publication Date Title
EE9900343A (et) Sünteetiline polünukleotiid, immuunvastuste tekitamise meetod, immunogeenne kompositsioon, anti-HIV immuunvastuste indutseerimise meetod, meetod antigeeni tekitava raku indutseerimiseks ja farmatseutiline kompositsioon
ES2190784T3 (es) Supresion de enfermedades autoinmunes por antigenos espectadores.
ATE326479T1 (de) Varianten von antigenen des menschlichen papillomvirus
IL134392A0 (en) Vaccine against hpv
HK1130069A1 (en) Tumor antigen based on products of the tumor suppressor gene wt1 wt1
ZA9811501B (en) Method to enhance an immune response of nucleic acid vaccination.
ATE233101T1 (de) Polynukleotide vakzine gegen den papilloma virus
NO931372L (no) Behandling av autoimmunsykdommer ved oral administrering av autoantigener
PT584348E (pt) Vacina genetica para virus da imunodeficiencia
MX9603124A (es) Vacuna contra el virus de la enfermedad de newcastle benigna.
HUP9701586A2 (hu) Javított inaktivált vakcinák
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
EP0626008A4 (en) Vaccine containing acemannan as an adjuvant.
NL300336I1 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
EP0290565A4 (en) VACCINE CONTAINING TICK ANTIGENS.
GB2227936A (en) Vaccine against brucella abortus
ZA903142B (en) Canine corona virus vaccine
IT1276509B1 (it) Vaccino per la profilassiimmunitaria dell'infezione da virus della immunodeficienza felina del gatto domestico.
BR9814556A (pt) Cepas isoladas de staphylococcus aureus e vacinas fabricadas a partir das mesmas
PL297941A1 (en) Inactivated coulour coded poultry vaccine
CS578887A1 (en) Inactivated antigen of cattle's mucosal disease's virus
ZA883365B (en) Newcastle disease virus vaccine and method for the application thereof